These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10504820)

  • 41. Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder.
    Popper CW
    Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):605-46, viii. PubMed ID: 10944659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder.
    Brams M; Mao AR; Doyle RL
    Postgrad Med; 2008 Sep; 120(3):69-88. PubMed ID: 18824827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
    Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome.
    Spencer T; Biederman J; Kerman K; Steingard R; Wilens T
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):354-60. PubMed ID: 8444765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanism of action of alpha 2A-adrenergic agonists in attention-deficit/hyperactivity disorder with or without oppositional symptoms.
    Stahl SM
    J Clin Psychiatry; 2010 Mar; 71(3):223-4. PubMed ID: 20331927
    [No Abstract]   [Full Text] [Related]  

  • 46. Clonidine for self-injurious behavior.
    Symons FJ; Thompson A; Realmuto G
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1324-5. PubMed ID: 15502588
    [No Abstract]   [Full Text] [Related]  

  • 47. Clonidine: a practical guide for usage in children.
    Oesterheld J; Tervo R
    S D J Med; 1996 Jul; 49(7):234-7. PubMed ID: 8755459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Case study: behavioral symptoms of pediatric HIV-1 encephalopathy successfully treated with clonidine.
    Ceseña M; Lee DO; Cebollero AM; Steingard RJ
    J Am Acad Child Adolesc Psychiatry; 1995 Mar; 34(3):302-6. PubMed ID: 7896670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sapophagia (compulsive soap eating) and attention-deficit/hyperactivity disorder in a child responsive to clonidine.
    Saddichha S; Vibha P; Vishnuvardhan G
    J Clin Psychopharmacol; 2012 Apr; 32(2):291. PubMed ID: 22388159
    [No Abstract]   [Full Text] [Related]  

  • 50. Clonidine therapy for comorbid attention deficit hyperactivity disorder and conduct disorder: preliminary findings in a children's inpatient unit.
    Schvehla TJ; Mandoki MW; Sumner GS
    South Med J; 1994 Jul; 87(7):692-5. PubMed ID: 8023201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trends and toxic effects from pediatric clonidine exposures.
    Klein-Schwartz W
    Arch Pediatr Adolesc Med; 2002 Apr; 156(4):392-6. PubMed ID: 11929375
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety of clonidine and nortriptyline.
    Chapman NA
    J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):142-3. PubMed ID: 8138513
    [No Abstract]   [Full Text] [Related]  

  • 53. Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology.
    Wilens TE; Spencer T; Biederman J; Wozniak J; Connor D
    J Am Acad Child Adolesc Psychiatry; 1995 Jan; 34(1):110-2. PubMed ID: 7860450
    [No Abstract]   [Full Text] [Related]  

  • 54. A 1000-fold overdose of clonidine caused by a compounding error in a 5-year-old child with attention-deficit/hyperactivity disorder.
    Romano MJ; Dinh A
    Pediatrics; 2001 Aug; 108(2):471-2. PubMed ID: 11483818
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clonidine: adverse responses.
    Levy F
    J Paediatr Child Health; 1998 Dec; 34(6):501-2. PubMed ID: 9928638
    [No Abstract]   [Full Text] [Related]  

  • 56. Alpha 2 adrenergic agonists. Neurochemistry, efficacy, and clinical guidelines for use in children.
    Newcorn JH; Schulz K; Harrison M; DeBellis MD; Udarbe JK; Halperin JM
    Pediatr Clin North Am; 1998 Oct; 45(5):1099-22, viii. PubMed ID: 9884677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clonidine poisoning--an emerging problem: epidemiology, clinical features, management and preventative strategies.
    Erickson SJ; Duncan A
    J Paediatr Child Health; 1998 Jun; 34(3):280-2. PubMed ID: 9633978
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Randomized double-blind controlled study on treatment of tic disorders in children with transcutaneous patch of clonidine].
    Zhong YQ; Zhou WZ; Hu WG
    Zhonghua Er Ke Za Zhi; 2007 Oct; 45(10):785-7. PubMed ID: 18211768
    [No Abstract]   [Full Text] [Related]  

  • 59. Clonidine in a case of atypical tic disorder.
    Haskell EL; Joffe R
    Can J Psychiatry; 1984 Dec; 29(8):704-6. PubMed ID: 6518445
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ECG and clonidine.
    Chandran KS
    J Am Acad Child Adolesc Psychiatry; 1994; 33(9):1351-2. PubMed ID: 7995805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.